clearly
bedrocan allocated some of their budget to stockhouse and got parry on board. true to their word we are starting to see some promotion and get a little insight into out Canadian version of an older experienced producer of mmpr. parry's article is a good read and even though our share price had a little run from over-exuberance we are leveling out now. It's a rare thing to see a profit this early from a new company and I think the direction is up as investors learn our story. glta